The ICPerMed "Best Practice in Personalised Medicine" Recognition 2019 aims to recognise, encourage, promote and disseminate outstanding examples of best practices in personalised medicine.
This second edition was open to candidates worldwide, who have published scientific papers and/or developed best practice strategies in the field of personalised medicine between January 1st, 2017 and October 31st 2018. The deadline for proposal submission was the 4th February 2019.
The winners of the of the ICPerMed "Best Practice in Personalised Medicine" Recognition 2019 are:
- A Liquid Biopsy ‘hub’: integrating Nano-technologies to improve cancer diagnosis and therapy
Patrizio Giacomini, RCSS National Cancer Institute Regina Elena, Italy
- Best Open Innovation in Science Practice for the Establishment of Interdisciplinary & Inter-Sectoral Collaboration Platforms for the Implementation of PM
Juergen Busch, Ludwig Boltzmann Gesellschaft, Austria
Gertraud Leimueller, winnovation – Open Innovation Research, Austria
L. Malfent, Ludwig Boltzmann Gesellschaft, Austria
J. Niebauer, Paracelsus Medical University & University Hospital Salzburg, Austria
H. Willschke, Medical University & University Hospital Vienna, Austria
- Translating genotype data into clinical pharmacogenetic recommendations: challenges and solutions
Sulev Reisberg, University of Tartu, Estonia
Kristi Krebs, Maarja Lepamets, Mart Kals, Reedik Magi, Kristjan Metsalu, Jaak Vilo, Lili Milani, University of Tartu, Estonia
Volker M. Lauschke, Karoslinska Institutet, Sweden
- Development and integration of organoid models in personalised medicine platforms
Mark A. Rubin, University of Bern, Switzerland
The successful applicants were invited to the ICPerMed Workshop 2019 and were given the opportunity to present their results during a plenary session. In addition, the successful candidates received support for the dissemination of the best practice example by the ICPerMed Secretariat in the value of 500 €.
The applications cover at least one of the three defined topics linked to “Personalised Medicine for all citizens and patients within sustainable health systems, including models to facilitate investment in disease prevention and therapy research”. The best practice examples can consist of one or several of the following:
- Scientific paper focused on novel approaches for the implementation of personalised medicine
- Training programmes for health personnel, increasing the level of awareness on the potential of personalised medicine
- Examples for interdisciplinary or intersectoral groups of collaboration (governmental and non-governmental organisations, academic management, medical research, Health Care and SME), for the implementation of personalised medicine, including ELSI activities.
ICPerMed assembles over 40 European and international partners representing ministries, funding agencies and the European Commission. With the support of the ICPerMed Secretariat, the consortium works on coordinating and supporting research to develop approaches for personalised medicine. Thereby, the central aim of ICPerMed is to align and encourage joint efforts in personalised medicine research and implementation on a European and international level.